TheProfitWatch

TPST - Tempest Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
3.65 -0.23 (-6.3%) --- --- -0.01 (-0.36%) 0.05 (1.37%) -0.19 (-5.26%) -0.04 (-1.05%) 0.01 (0.27%)

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-2.07
Diluted EPS:
-2.07
Basic P/E:
-1.6522
Diluted P/E:
-1.6522
RSI(14) 1m:
55.56
VWAP:
3.42
RVol:

Events

Period Kind Movement Occurred At

Related News